Cell transformation by c-Ha-rasVal12 oncogene is accompanied by a decrease in histone H1° and an increase in nucleosomal repeat length
Corresponding Author
Jens Laitinen
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Department of Pathology, University of Helsinki, P.O. Box 21, (Haartmaninkaty 3). FIN-00014 Helsinki, FinlandSearch for more papers by this authorLea Sistonen
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorKari Alitalo
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorErkki Hölttä
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorCorresponding Author
Jens Laitinen
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Department of Pathology, University of Helsinki, P.O. Box 21, (Haartmaninkaty 3). FIN-00014 Helsinki, FinlandSearch for more papers by this authorLea Sistonen
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorKari Alitalo
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorErkki Hölttä
Department of Pathology, University of Helsinki, FIN-00014 Helsinki, Finland
Search for more papers by this authorAbstract
The activated c-Ha-rasVal12 oncogene is often involved in the genesis of human malignancies. We show here that in c-Ha-rasVal12 oncogene-transformed mouse NIH 3T3 fibroblasts the copy number and expression level of the mutant ras oncogene correlates with the degree of chromatin decondensation, as assessed by micrococcal nuclease (MNase) and DNase I digestion. MNase and DNase I analyses further revealed that the nucleosomal repeat lengths were different in the normal and ras oncogene-transformed cells, 162.3 bp and 178.1 bp, respectively. These chromatin changes were accompanied by alterations in the content of histone H1°. Furthermore, using DNase I as a probe, we discovered that serum stimulation of normal and transformed cells, synchronized by serum starvation, induces rapid reversible changes in the structure of bulk chromatin that may be linked to transcriptional activation. Our data thus indicate that cell transformation by ras is associated with specific changes in chromatin structure that make it more vulnerable, and prone to additional mutations characteristic of cancer development in vivo.
References
- Allan, J, Staynov DZ, Gould G (1980): Reversible dissociation of linker histone from chromatin with preservation of internucleosomal repeat. Proc Natl Acad Sci USA 77: 885–889.
- Annunziato AT, Seale RL (1982): Maturation of nucleosomal and nonnucleosomal components of nascent chromatin: Differential requirements for concurrent protein synthesis. Biochemistry 21: 5431–5438.
- Barbacid M (1987): ras genes. Annu Rev Biochem 56: 779–827.
- Biard-Roche J, Gorka C, Lawrence J-J (1982): The structural role of histone H1: Properties of reconstituted chromatin with various H1 subfractions (H1-1, H1-2 and H1°). EMBO J 1: 1487–1492.
- Bishop JM (1991): Molecular themes in oncogenesis. Cell 64: 235–248.
- Bonifer C, Hecht A, Sauerressig H, Winter DM, Sippel AE (1991): Dynamic chromatin: The regulatory domain organization of eukaryotic gene loci. J Cell Biochem 47: 1–10.
- Bremner R, Balmain A (1990): Genetic changes in skin tumor progression. Correlation between presence of a mutant ras gene and loss of heterozygosity on mouse chromosome 7. Cell 61: 407–417.
- Chen TA, Allfrey VG (1987): Rapid and reversible changes in nucleosome structure accompany the activation, repression and superinduction of murine fibroblast protooncogenes c-fos and c-myc. Proc Natl Acad Sci USA 84: 5252–5256.
- Chen TA, Sterner R, Cozzolino A, Allfrey VG (1990): Reversible and irreversible changes in nucleosome structure along the c-fos and c-myc oncogenes following inhibition of transcription. J Mol Biol 212: 481–493.
- Compton J, Bellard LM, Chambon P (1976): Biochemical evidence of variability in the DNA repeat length in the chromatin of higher eukaryotes. Proc Natl Acad Sci USA 73: 4382–4386.
- D'Anna JA, Prentice DA (1983): Chromatin structural changes in synchronized cells blocked in early S phase by sequential use of isoleucine deprivation and hydroxyurea blockade. Biochemistry 22: 5631–5640.
- D'Anna JA, Tobey RA (1989): Changes in nucleosomal repeat lengths precede replication in the early replicating metallothionein II gene region of cells synchronized in early S phase. Biochemistry 28: 2895–2902.
- D'Anna JA, Gurley R, Tobey RA (1982). Synthesis and modulations in the chromatin contents of histones H1° and H1 during G1 and S phase in Chinese hamster cells. Biochemistry 21: 3991–4001.
- Drews RE, Chan WT-W, Schnipper LE (1992): Oncogenes result in genomic alterations that activate a transcriptionally silent, dominantly selectable reporter gene (neo). Mol Cell Biol 12: 198–206.
- Felsenfeld G (1992): Chromatin as an essential part of the transcriptional mechanism. Nature 355: 219–224.
- Feng J, Villeponteau B (1990): Serum stimulation of the c-fos enhancer induces reversible changes in c-fos chromatin structure. Mol Cell Biol 10: 1126–1133.
-
Gutman A,
Wasylyk B
(1991):
Nuclear targets for transcription regulation by oncogenes.
Trends Genet
2: 49–54.
10.1016/0168-9525(91)90231-E Google Scholar
- Holthuis J, Owen TA, Wijnen AJ, Wright KL, Ramsay-Ewing A, Kennedy MB, Carter R, Cosenza SC, Soprano KJ, Lian JB, Stein JL, Stein GS (1990): Tumour cells exhibit deregulation of the cell cycle histone gene promoter factor Hinf-D. Science 247: 1454–1457.
- Herschman HR (1991): Primary response genes induced by growth factors and tumour promoters. Annu Rev Biochem 60: 281–319.
- Hölttä E, Sistonen L, Alitalo K (1988): The mechanisms of ornithine decarboxylase deregulation in c-Ha-ras oncogene-transformed NIH 3T3 cells. J Biol Chem 263: 4500–4507.
- Hunter T (1991): Cooperation between oncogenes. Cell 64: 249–270.
- Keppel F, Allet B, Eisen H (1979): Biochemical properties and localization of the chromosomal protein IP25. Eur J Biochem 96: 477–482.
- Laemmli UK (1970): Cleavage of the structural proteins of the head of bacteriophage T4. Nature 227: 680–685.
- Laitinen J, Hölttä E (1994): Methylation status and chromatin structure of an early response gene (ornithine decarboxylase) in resting and stimulated NIH-3T3 fibroblasts. J Cell Biochem 55: 155–165.
- Laitinen J, Sistonen L, Alitalo K, Hölttä E (1990): c-Ha-rasVal12 oncogene-transformed NIH-3T3 fibroblasts display more decondensed nucleosomal organization than normal fibroblasts. J Cell Biol 111: 9–17.
- Leonardson KE, Levy SB (1989): Chromatin reorganization during emergence of malignant friend tumors. Early changes in H2A and H2B variants and nucleosome repeat length. Exp Cell Res 180: 209–219.
- Lloyd A, Yancheva N, Wasylyk B (1991): Transformation suppressor activity of a Jun transcription factor lacking its activation domain. Nature 352: 635–638.
- Marx J (1993): New colon cancer gene discovered. Science 260: 751–752.
- McCormick F (1993): How receptors turn Ras on. Nature 363: 15–16.
- Moreno ML, Chrysogelos SA, Stein GS, Stein JL (1986): Reversible changes in the nucleosomal organization of a human H4 histone gene during the cell cycle. Biochemistry 25: 5364–5370.
- Noll M, Kornberg RD (1977): Action of micrococcal nuclease on chromatin and the localization of histone H1. J Mol Biol 109: 393–404.
- Nowell PC (1986): Mechanisms of tumor progression. Cancer Res 46: 2203–2207.
- Osborne HB, Chabanas A (1984): Kinetics of histone H1° accumulation and commitment to differentiation in murine erythroleukemia cells. Exp Cell Res 152: 449–458.
- Pehrsson J, Cole D (1980): Histone H1° accumulates in growth-inhibited cultured cells. Nature 285: 43–44.
- Pryciak PM, Sill A, Varmus HE (1992): Retroviral integration into minichromosomes in vitro. EMBO J 11: 291–303.
- Roche J, Gorka CI, Goeltz P, Lawrence JJ (1985): Association of histone H1° with a gene repressed during liver development. Nature 314: 197–198.
- Rousseau D, Khochbin S, Gorka C, Lawrence J-J (1991): Regulation of histone H1(0) accumulation during induced differentiation of murine erythroleukemia cells. J Mol Biol 217: 85–92.
- Sambrook J, Fritsch EF, Maniatis T (1989): “ Molecular Cloning. A Laboratory Manual.” 2nd Ed. Cold Spring Harbor, New York. Cold Spring Harbor Laboratory.
- Sistonen L, Keski-Oja J, Ulmanen I, Hölttä E, Wikgren B-J, Alitalo K (1987): Dose effects of transfected c-Ha-rasVal12 oncogene in transformed cell clones. Exp Cell Res 168: 518–530.
- Sistonen L, Hölttä E, Mäkelä TP, Keski-Oja J, Alitalo K (1989): The cellular response to induction of the p21 c-Ha-ras oncoprotein includes stimulation of jun gene expression. EMBO J 8: 815–822.
- Smith RD, Seale RL, Yu J (1983): Transcribed chromatin exhibits altered nucleosomal spacing. Proc Natl Acad Sci USA 80: 5505–5509.
- Sperling L, Tardieu A, Weiss MC (1980): Chromatin repeat length in somatic hybrids. Proc Natl Acad Sci USA 77: 2716–2720.
- Sun J-M, Ali Z, Lurz R, Ruiz-Carillo A (1990): Replacement of histone H1 by H5 in vivo does not change the nucleosomal repeat length of chromatin but increases its stability. EMBO J 9: 1651–1658.
- Tan KB, Borun TW, Carpentier R, Cristofalo VL, Croce CM (1982): Normal and neoplastic human cells have different histone H1 compositions. J Biol Chem 257: 5337–5338.
- Wasylyk C, Imler JL, Wasylyk B (1988): Transforming but not immortalizing oncogenes activate the transcription factor PEA 1. EMBO J 7: 2475–2483.
- Weintraub H (1984): Histone-H1-dependent chromatin superstructures and the suppression of gene activity. Cell 38: 17–27.
- Wolffe AP (1991): Developmental regulation of chromatin structure and function. Trends Biochem Sci 1: 61–66.
- Yu J, Smith RD (1985): Sequential alterations in globin gene chromatin structure during erythroleukemia cell differentiation. J Biol Chem 260: 3035–3040.